Craig Hallum began coverage on shares of Elanco Animal Health (NASDAQ:ELAN) in a research report sent to investors on Friday, The Fly reports. The firm issued a hold rating on the stock.
Several other analysts have also commented on ELAN. Gabelli started coverage on Elanco Animal Health in a report on Wednesday, September 19th. They set a buy rating and a $32.00 price objective for the company. BMO Capital Markets started coverage on Elanco Animal Health in a report on Wednesday, September 26th. They set a market perform rating and a $33.00 price objective for the company.
Elanco Animal Health stock traded up $0.19 during mid-day trading on Friday, reaching $32.58. 1,324,881 shares of the company were exchanged, compared to its average volume of 2,635,356. Elanco Animal Health has a 12-month low of $31.76 and a 12-month high of $37.61.
In other Elanco Animal Health news, Director Lawrence Erik Kurzius acquired 10,000 shares of the firm’s stock in a transaction dated Monday, September 24th. The stock was purchased at an average price of $24.00 per share, for a total transaction of $240,000.00. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Jeffrey N. Simmons acquired 22,000 shares of the firm’s stock in a transaction dated Monday, September 24th. The shares were acquired at an average price of $24.00 per share, with a total value of $528,000.00. The disclosure for this purchase can be found here. In the last quarter, insiders have bought 33,000 shares of company stock valued at $792,000.
About Elanco Animal Health
There is no company description available for Elanco Animal Health Inc
Featured Article: What do I need to know about analyst ratings?
Receive News & Ratings for Elanco Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elanco Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.